Summary
Philip Morris International Inc. (PM) has filed an 8-K report detailing its progress in acquiring Vectura Group plc. As of August 17, 2021, PM has successfully acquired a significant minority stake of 22.61% in Vectura's issued share capital through market purchases executed outside the United States. This move precedes the formal commencement of PM's tender offer for the remaining shares of Vectura. This partial acquisition demonstrates PM's commitment to the Vectura deal and signals proactive execution in securing a substantial interest in the company. Investors should monitor the progress of the tender offer, as the successful completion of this acquisition is intended to expand PM's presence in the inhaled medicines and respiratory drug delivery space, aligning with its broader strategy to pivot towards a smoke-free future.
Key Highlights
- 1Philip Morris International (PM) has acquired 22.61% of Vectura Group plc's issued share capital.
- 2The acquisition of Vectura shares occurred on August 17, 2021, through market purchases outside the U.S.
- 3This purchase is in connection with PM's previously announced tender offer for Vectura Group plc.
- 4The filing is an 8-K Current Report, indicating a material event.
- 5Additional information regarding the tender offer is available on PM's website.
- 6The information furnished is not deemed 'filed' under Section 18 of the Securities Exchange Act, limiting liability.